14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CYTR
Delisted

CytRx Corporation Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0920
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0920 $0.0920 Friday, 27th Jan 2023 CYTR stock ended at $0.0920. During the day the stock fluctuated 0% from a day low at $0.0920 to a day high of $0.0920.
90 days $0.0920 $0.0920
52 weeks $0.0520 $0.520

Historical CytRx Corporation prices

Date Open High Low Close Volume
Dec 20, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 19, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 16, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 15, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 14, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 13, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 12, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 09, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 08, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 07, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 06, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 05, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 02, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Dec 01, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 30, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 29, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 28, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 25, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 23, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 22, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 21, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 18, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 17, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 16, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Nov 15, 2022 $0.0920 $0.0920 $0.0920 $0.0920 0
Click to get the best stock tips daily for free!

About CytRx Corporation

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and A... CYTR Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT